Literature DB >> 26728908

Estimating Economic Burden of Cancer Deaths Attributable to Smoking in Iran.

Satar Rezaei1, Ali Akbari Sari2, Mohammad Arab2, Reza Majdzadeh2, Asghar Mohammadpoorasl3.   

Abstract

BACKGROUND: There is a broad consensus among health policy-makers that smoking has a significant impact on both heath system and society. The purpose of this study was to estimate the economic burden of major cancer deaths caused by smoking in Iran in 2012.
METHODS: Number of major cancer deaths due to smoking by sex and age groups in 2012 was obtained from GLOBCAN database. The life expectancy and retirement age were used to estimate years of potential life lost (YPLL) and cost of productive lost attributable to smoking, respectively. Data on prevalence of smoking, relative risk of smoking, life expectancy table, annual wage and employment rate were extracted from the various resources such as previous studies, WHO database and Iranian statistic centers. The data analysis was conducted by Excel software.
RESULTS: Smoking was responsible for 4,623 cancer deaths, 80808 YPLL and $US 83,019,583 cost of productivity lost. Lung cancer accounts for largest proportion of total cancer deaths, YPLL and cost of productivity lost attributable to smoking. Males account for 86.6% of cancer deaths, 82.6% of YPLL and 85.3% of cost of productivity lost caused by smoking.
CONCLUSIONS: Smoking places a high economic burden on health system and society as a whole. In addition, if no one had been smokers in Iran, approximately two out of ten cancer deaths could be prevented.

Entities:  

Keywords:  Cancer; Economic Burden; Iran; Smoking

Mesh:

Year:  2015        PMID: 26728908

Source DB:  PubMed          Journal:  J Res Health Sci        ISSN: 2228-7795


  13 in total

Review 1.  Molecular epidemiology of lung cancer in Iran: implications for drug development and cancer prevention.

Authors:  Zahra Fathi; Nicholas L Syn; Jian-Guo Zhou; Raheleh Roudi
Journal:  J Hum Genet       Date:  2018-04-18       Impact factor: 3.172

2.  Suggesting Approaches of Tobacco Control for Policymakers: A Serious Challenge of Iranian Future Health.

Authors:  Mousa Bamir; Ali Masoud; Reza Dehnavieh; Fakhri Ebrahimi
Journal:  Addict Health       Date:  2020-10

3.  Impact of Smoking on Health-Related Quality of Life: A General Population Survey in West Iran

Authors:  Satar Rezaei; Behzad Karami Matin; Ali Kazemi Karyani; Abraha Woldemichael; Farid Khosravi; Masoud Khosravipour; Shahab Rezaeian
Journal:  Asian Pac J Cancer Prev       Date:  2017-11-26

4.  Estimating the Economic Burden of Lung Cancer in Iran

Authors:  Satar Rezaei; Ali Akbari Sari; Abraha Woldemichael; Moslem Soofi; Ali Kazemi; Behzad Karami Matin
Journal:  Asian Pac J Cancer Prev       Date:  2016-10-01

5.  Productivity costs and years of potential life lost associated with five leading causes of death: Evidence from Iran (2006-2010).

Authors:  Farid Najafi; Behzad Karami-Matin; Satar Rezaei; Ardashir Khosravi; Moslem Soofi
Journal:  Med J Islam Repub Iran       Date:  2016-09-07

6.  Does smoking status affect cost of hospitalization? Evidence from three main diseases associated with smoking in Iran.

Authors:  Ali Akbari Sari; Satar Rezaei; Mohammad Arab; Behzad Karami Matin; Reza Majdzadeh
Journal:  Med J Islam Repub Iran       Date:  2017-09-23

7.  Economic burden of smoking: a systematic review of direct and indirect costs.

Authors:  Satar Rezaei; Ali Akbari Sari; Mohammad Arab; Reza Majdzadeh; Asghar Mohammad Poorasl
Journal:  Med J Islam Repub Iran       Date:  2016-07-13

8.  Economic Burden of Smoking in Iran: A Prevalence-Based Annual Cost Approach

Authors:  Satar Rezaei; Behzad Karami Matin; Mohammad Hajizadeh; Mohammad Bazyar; Ali Akbari Sari
Journal:  Asian Pac J Cancer Prev       Date:  2017-10-26

9.  Financial Aspect of Indian Suicides in 2015.

Authors:  Poduri Gopala Sarma
Journal:  Indian J Psychol Med       Date:  2018 May-Jun

10.  Socioeconomic inequality in tobacco expenditure in Iran: a cross-sectional analysis at national and subnational levels.

Authors:  Satar Rezaei; Mohammad Habibullah Pulok; Mohammad Ebrahimi
Journal:  BMC Public Health       Date:  2020-06-29       Impact factor: 4.135

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.